1.    PDF File (NCSAUA-05-135.pdf    58 Kb)
Nandipati, KC, Raina, R, Bhatt, A, Agarwal, A, Phillippi, A, Ochoa, R, and Zippe, CD (2005):
Early combination therapy following radical prostatectomy (RP): Intracorporal alprostadil and sildenafil promotes early return of natural erections.
Abstract #135
 

2.    PDF File (NCSAUA-05-136.pdf    72 Kb)
Nandipati, KC, Raina, R, Agarwal, A, and Zippe, CD (2005):
Early daily sildenafil following prostate brachytherapy preserves erectile function.
Abstract #136
 

3.    PDF File (NCSAUA-05-159.pdf    72 Kb)
Raina, R, Nandipati, KC, Agarwal, A, and Zippe, CD (2005):
Early penile rehabilitation after radical prostatectomy (RP): role of non-oral treatments.
Abstract #159
 

4.    PDF File (NCSAUA-05-68.pdf    49 Kb)
Raina, R, Nandipati, KC, Agarwal, A, and Zippe, CD (2005):
Efficacy of sildenafil for erectile dysfunction after radical prostatectomy (RP): long term follow-up.
Poster #68
 

1.    PDF File (NCSAUA-04-359.pdf    59 Kb)
Zaramo, CEB, Raina, R, Agarwal, A, Gill, I, and Zippe, CD:
Survival factors in corporal cavernosal cells following radical prostatectomy: a canine model.
Abstract #359, Oral Presentation
 

2.    PDF File (NCSAUA-04-361.pdf    60 Kb)
Raina, R, Zaramo, CEB, Ausmundson, S, Agarwal, A, Jones, JS, and Zippe, CD:
Early MUSE treatment after radical prostatectomy facilitates sexual activity.
Abstract #361
 

3.    PDF File (NCSAUA-04-366.pdf    52 Kb)
Raina, R, Zaramo, CEB, Agarwal, A, Ulchaker, J, Jones, JS, Klein, E, and Zippe, CD:
Sexual function following male radical cystectomy in a sexually active population.
Abstract #366, Oral Presentation
 

4.    PDF File (NCSAUA-04-368.pdf    42 Kb)
Zaramo, CEB, Raina, R, Agarwal, A, and Zippe, CD:
Factors predicating successful outcome of sildenafil citrate following radical prostatectomy.
Abstract #368, Oral Presentation
 

1.    PDF File (NCSAUA-03-001.pdf    55 Kb)
Jackson, C, Raina, R, Shah, AD, Agarwal, A, Jones, JS, Ulchaker, J, Klein, EA, and Zippe, CD:
Use of sildenafil citrate for treatment of erectile dysfunction following male radical cystectomy (RC).
Podium Presentation.
 

2.    PDF File (NCSAUA-03-002.pdf    56 Kb)
Jackson, C, Raina, R, Shah, AD, Agarwal, A, Jones, JS, Ulchaker, J, Klein, EA, and Zippe, CD:
Sexual dysfunction (FSD) following female radical cystectomy (RC): IFSF-10 analysis.
Podium Presentation.
 

3.    PDF File (NCSAUA-03-003.pdf    46 Kb)
Raina, R, Agarwal, A, and Zippe, CD:
Combination therapy (MUSE and sildenafil citrate) for erectile dysfunction following radical prostatectomy (RP).
Podium Presentation.
 

4.    PDF File (NCSAUA-03-60.pdf    56 Kb)
Jackson, C, Goyal, K, Raina, R, Agarwal, A, Ciezki, J, and Zippe, CD:
Long-term potency following I-125 radiation therapy for prostate cancer and role of sildenafil citrate.
Abstract #60.
 

5.    PDF File (NCSAUA-03-005.pdf    48 Kb)
Goyal, K, Raina, R, Agarwal, A, and Zippe, CD:
Treatment decisions of sexually active patients following radical prostatectomy (RP).
Podium Presentation.
 

6.    PDF File (NCSAUA-03-61.pdf    55 Kb)
Raina, R, Ausmudson, S, Agarwal, A, Jones, JS, and Zippe, CD:
Early MUSE treatment following radical prostatectomy (RP).
Abstract #61.
 

1.    PDF File (NCSAUA-02-001.pdf    66 Kb)
Raina, R, Agarwal, A, and Zippe, CD:
Efficacy of early use vacuum constriction device (VCD) for erectile dysfunction (ED) following radical prostatectomy (RP).
Oral presentation.
 

2.    PDF File (NCSAUA-02-002.pdf    65 Kb)
Raina, R, Agarwal, A, and Zippe, CD:
Three year efficacy of sildenafil citrate following radical prostatectomy: SHIM (IIEF-5) analysis).
Oral presentation.
 

3.    PDF File (NCSAUA-02-17.pdf    59 Kb)
Raina, R, Ausmundson, S, Agarwal, A, Lakin, MM, and Zippe, CD:
Long-term intracavernous (IC) therapy responders can potentially switch to sildenafil citrate after radical prostatectomy (RP).
Poster #17.
 

4.    PDF File (NCSAUA-02-004.pdf    69 Kb)
Raina, R, Ausmundson, S, Oder, M, Agarwal, A, Lakin, MM, and Zippe, CD:
Role of intracorporeal (IC) injections treatment for erectile dysfunction (ED) following radical prostatectomy (RP): SHIM (IIEF-5) analysis.
Oral presentation.
 

1.    PDF File (NCSAUA-01-001.pdf    55 Kb)
Raina, R., Sharma, S., Ponsky, L.E., Nelson, D.R., Agarwal, A., and Zippe, C.D.:
Atypical cytology indexed to NMP22: role in the screening and monitoring of bladder cancer.
Oral presentation.
 

2.    PDF File (NCSAUA-01-002.pdf    55 Kb)
Raina, R., Agarwal, A., and Zippe, C.D.:
NMP22 enhances the detection rate of both low and high grade bladder cancers.
 

1.    PDF File (NCSAUA-00-1.pdf    184 Kb)
S. Sharma, L. Ponsky, S. Kedia, A. Agarwal, D.R. Nelson, and C.D. Zippe:
Atypical cytology indexed to NMP22: role in the early detection and monitoring of bladder cancer,
Abstract #1.
 

2.    PDF File (NCSAUA-00-4.pdf    278 Kb)
M. Thukral, M.M. Lakin, A. Agarwal, D.K. Montague, and C.D. Zippe:
Analysis of intracorporeal (IC) penile injection treatment based on the IIEF questionnaire in patients with erectile dysfunction following radical prostatectomy.
Abstract #4.
 

3.    PDF File (NCSAUA-00-5.pdf    1431 Kb)
L. Ponsky, R. Starkey, K. Goyal, A. Agarwal, D. Neumann, and C.D. Zippe:
Correlation of indium-111 capromab penetide with postoperative histology following radical prostatectomy.
Abstract #5.
 

4.    PDF File (NCSAUA-00-7.pdf    1516 Kb)
E. Cherullo, F.F. Pasqualotto, V. Sekhon, M. Srivastava, K. Goyal, A. Agarwal, E. Klein, and C.D. Zippe:
Sextant lateral base TRUS-guided biopsy technique is superior to the sextant parasagittal technique.
Abstract #7.
 

1.    PDF File (NCSAUA-98-001.pdf    467 Kb)
Sharma, S., Pandrangi, L., Nelson, D., Agarwal, A., and Zippe, C.:
Office BTA stat versus laboratory BTA Trak and NMP22 test: comparison study. Oral Presentation.
 

2.    PDF File (NCSAUA-98-002.pdf    138 Kb)
Potts, J., Sharma, R., Pasqualotto, F., and Agarwal, A.:
Leukocytospermia (ENDTZ) is unreliable in detecting ureaplasma urealyticum (UU) infections which may impair sperm function.
Oral Presentation.
 

3.    PDF File (NCSAUA-98-3.pdf    66 Kb)
Kedia, A., Agarwal, A., Nelson, D., Kedia, K., and Zippe, C.:
Influence of nerve-sparing radical prostatectomy (RP) on the efficacy of sildenafil citrate (Viagra).
Abstract #3.
 

4.    PDF File (NCSAUA-98-3a.pdf    243 Kb)
Agarwal, A., Pandrangi, L., Sharma, S., Nelson, D., and Zippe, C.:
Screening and monitoring of patients at risk for bladder cancer by two new urinary markers.
Abstract #3a.
 

5.    PDF File (NCSAUA-98-005.pdf    131 Kb)
Kedia, A., Pasqualotto, F., Agarwal, A., Nelson, D., Kedia, K., and Zippe, C.:
Comparison of anti-androgens and LHRH agonists in the treatment of localized prostate cancer.
Oral Presentation.
 

6.    PDF File (NCSAUA-98-2.pdf    132 Kb)
Zippe, C., Pandrangi, L., Nelson, D., and Agarwal, A.:
Screening for bladder cancer: the evolving use of NMP22 as a sensitive, cost effective urinary marker.
Abstract #2.
 

7.    PDF File (NCSAUA-98-10.pdf    68 Kb)
Goyal, K., Agarwal, A., Kedia, A.W., Nelson, D., Levin, H., and Zippe, C.D.:
Impact of nerve-sparing radical prostatectomy on margin status in low and high volume prostate cancer.
Abstract #10.